Journals

NEW ISN-KI Early Career Researcher Award: Best Clinical and Basic Science publications in Kidney International

Kidney International has published many exciting research papers by Early Career Researchers across the globe in the last 2 years. We would like to recognize the exceptional quality of their research and their contribution to advancing kidney health by calling for nominations from our membership for the best original research papers published in Kidney International in 2019 and 2020....

Call For Nominations: ISN-KI Early Career Researcher Award

In recognition of Early Career Researchers, the ISN and Kidney International (KI) are calling for nominations toward selecting four best original research papers (two each in basic and clinical science) published in KI in 2019 and 2020. The nomination period opens on January 21, 2021. Papers will be assessed on the novelty of research, robustness, and...

Kidney International Highlights ISN’s 60th Anniversary Research and Historical Studies Series

“Milestones in nephrology and welcoming the future: the 61st anniversary of the International Society of Nephrology ” has been published in Kidney International. The year 2020 marked ISN’s 60th anniversary. In honor of this achievement, the ISN Research Working Group, supported by the ISN Young Nephrologists Committee, highlighted 60 + 1 breakthrough discoveries of significant...

ISN Journals

In July 2020, all three of the ISN journal websites (https://www.kidney-international.org/, https://www.kireports.org/, and https://www.kisupplements.org/), were converted from traditional article pages to a new responsive design format to better respond to the needs of readers and the devices they’re using. Kidney International Current Impact Factor 8.945 Submissions: 2745 Countries submitted: 72 Original research articles Reviewed: 506 Original research articles Accepted: 90 KI...

ISN Journals eDigest: A Companion to December Editions

The ISN released a companion ISN Journals eDigest last week to coincide with the December issue of Kidney International dedicated to the COVID-19 pandemic. Packed with complementary material, including visual abstracts, video abstract, and podcast, the ISN Journals eDigest content is also available on the ISN website. Look out for more ISN Journal eDigests in the...

Caring for Patients with Kidney Failure: Ten-Year Strategy

This month’s Supplement to Kidney International features the detailed description of a global strategic plan for care of patients with kidney failure. The strategy is to be implemented progressively over the next decade. As noted in the accompanying editorial, there is a huge gap between the total global number of patients with kidney failure and...

KI publishes ISN’s International Consensus Definitions of Clinical Trial Outcomes for Kidney Failure: 2020

Kidney International has published the International Consensus Definitions of Clinical Trial Outcomes for Kidney Failure: 2020, developed from the 1st International Consensus Meeting on Defining Kidney Failure in Clinical Trials hosted by the ISN in Vancouver, BC, Canada, in early 2020. Kidney failure is an important outcome for patients, clinicians, researchers, healthcare systems, payers, and regulators. However,...

International Perspectives on Patient Involvement in Clinical Trials in Nephrology

The involvement of patients in nephrology clinical trials is limited despite their ability to prioritize research, help with study design, participation, and implementation of results. The aim of this position paper is to review the need for and challenges of patient involvement; to assess the present situation of patient involvement; and to describe the...

Functional Assessment of Fatigue and Other Patient-Reported Outcomes in Patients Enrolled in the Global aHUS Registry

This longitudinal studyassessedfatigue and treatment status in patients with Atypical hemolytic uremic syndrome (aHUS) from the Global aHUS Registry. The results confirm the detrimental effects of aHUS on patients’ daily lives, especially in terms of fatigue,butdemonstratessignificant improvement in symptoms following treatment with eculizumab.